GAMMA Investing
BNTC icon

GAMMA Investing’s Benitec Biopharma BNTC Stock Holding History

GAMMA Investing’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$80.4K Buy
8,044
+83
+1% +$1.02K ﹤0.01% 2038
2026
Q2 		$107K Buy
7,961
+1,256
+19% +$14.9K ﹤0.01% 1765
2026
Q1 		$71.4K Sell
6,705
-20
-0.3% -$232 ﹤0.01% 1913
2025
Q4 		$90.6K Sell
6,725
-1
-0% -$14 ﹤0.01% 1651
2025
Q3 		$94.4K Buy
6,726
+734
+12% +$9.37K 0.01% 1540
2025
Q2 		$70.1K Buy
5,992
+27
+0.5% +$378 ﹤0.01% 1687
2025
Q1 		$77.6K Sell
5,965
-479
-7% -$5.8K 0.01% 1462
2024
Q4 		$81.4K Sell
6,444
-96
-1% -$1.04K 0.01% 1268
2024
Q3 		$60.1K Buy
6,540
+1,102
+20% +$9.9K 0.01% 1359
2024
Q2 		$38K Buy
5,438
+1,884
+53% +$13.9K 0.01% 1387
2024
Q1 		$18.7K Buy
3,554
+3,217
+955% +$12.3K ﹤0.01% 1700
2023
Q4 		$947 Buy
+337
New +$1.12K ﹤0.01% 2804

Other funds holding BNTC

Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing's BNTC Position: Q3 2026 in Review

GAMMA Investing increased its Benitec Biopharma (BNTC) stake by 1% in Q3 2026, buying an estimated $1.02K and bringing the position to 8,044 shares worth $80.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2038.

GAMMA Investing first reported a position in BNTC in Q4 2023 and has held it in 12 quarters since. The position peaked at $107K in Q2 2026. 4 funds tracked by Wall St. Rank hold BNTC as of Q3 2026.

  • GAMMA Investing held 8,044 shares of Benitec Biopharma worth $80.4K as of Q3 2026.
  • GAMMA Investing bought 83 Benitec Biopharma shares in Q3 2026, an estimated $1.02K.
  • Benitec Biopharma made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2038 holding.
  • GAMMA Investing first reported a position in Benitec Biopharma in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Benitec Biopharma position peaked at $107K in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.